Tissue compliance meter is a more reproducible method of measuring radiation-induced fibrosis than late effects of normal tissue-subjective objective management analytical in patients treated with intracavitary brachytherapy accelerated partial breast irradiation: Results of a prospective trial

Breast Journal

Volumn 19, Issue 3, 2013, Pages 250-258

  Wernicke, A Gabriella ^a   Greenwood, Eleni A ^a   Coplowitz, Shana ^a   Parashar, Bhupesh ^a   Kulidzhanov, Fridon ^a   Christos, Paul J ^a   Fischer, Andrew ^b   Nori, Dattatreyudu ^a   Chao, Kun S Clifford ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

accelerated partial breast irradiation; breast cancer; fibrosis; late effects of normal tissue subjective objective management analytical; radiation side effects; radiation induced fibrosis; tissue compliance meter

Indexed keywords

ACCELERATED PARTIAL BREAST IRRADIATION; ADULT; AGED; BRACHYTHERAPY; BREAST CANCER; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; DISEASE COURSE; DISEASE SEVERITY; DOSIMETRY; FEMALE; FOLLOW UP; HUMAN; MEDICAL DEVICE; PALPATION; PARTIAL MASTECTOMY; PATIENT CARE; PATIENT COMPLIANCE; PROSPECTIVE STUDY; RADIATION INDUCED FIBROSIS; RADIATION INJURY; REPRODUCIBILITY; REVIEW; TISSUE COMPLIANCE METER;

AGED; AGED, 80 AND OVER; BRACHYTHERAPY; BREAST; BREAST NEOPLASMS; FEMALE; FIBROSIS; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS;

EID: 84876806227     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/tbj.12102     Document Type: Review

References (43)

1. Giotopoulos G, Symonds RP, Foweraker K, et al,. The late radiotherapy normal tissue injury phenotypes of telangiectasia, fibrosis and atrophy in breast cancer patients have distinct genotype-dependent causes. Br J Cancer 2007; 96: 1001-7.
2. Moore GJ, Mendenhall NP, Kamath SS, Lind SS, Haigh LS, Copeland EM., Persistent symptomatology after breast conservation therapy: prevalence and impact on quality of life. Int J Radiat Oncol Biol Phys 1998; 42: 2058.
3. Delanian S, Lefaix J-L,. The radiation-induced fibro-atrophic process: therapeutic perspective via antioxidant pathway. Radiother Oncol 2004; 73: 119-31.
4. Hill RP, Rodemann HP, Hendry JH, Roberts SA, Anscher MS., Normal tissue radiobiology: from the laboratory to the clinic. Int J Radiat Oncol Biol Phys 2001; 49: 353-65.
5. Bentzen SM, Thames HD, Overgaard M,. Latent-time estimation for late cutaneous and subcutaneous radiation reactions in a single follow-up clinical study. Radiother Oncol 1989; 15: 267-74.
6. Bentzen SM, Dorr W, Anscher MS, et al,. Normal tissue effects: reporting and analysis. Semin Radiat Oncol 2003; 13: 189-202.
7. Fehlauer F, Tribius S, HoÂ̈ller U, et al,. Long-term radiation sequelae after breast conserving therapy in women with early- stage breast cancer: an observational study using the LENTSOMA scoring system. Int J Radiat Oncol Biol Phys 2003; 55: 651-8.
8. Hoeller U, Tribius S, Kuhlmey A, Grader K, Fehlauer F, Alberti W., Increasing the rate of late toxicity by changing the score? A comparison of RTOG/EORTC and LENT/SOMA scores. Int J Radiat Oncol Biol Phys 2003; 55: 1013-8.
9. Arthur DW, Vicini FA,. Accelerated partial breast irradiation as a part of breast conservation therapy. J Clin Oncol 2005; 23: 1726-35.
10. Vicini FA, Kestin L, Chen P, Benitez P, Goldstein NS, Martinez A., Limited-field radiation therapy in the management of early-stage breast cancer. J Natl Cancer Inst 2003; 95: 1205-10.
11. Delanian S, Lefaix JL,. Current management for late normal tissue injury: radiation induced fibrosis and necrosis. Semin Radiat Oncol 2007; 17: 99-107.
12. Delanian S, Baillet F, Huart J, Lefaix JL, Maulard C, Housset M., Successful treatment of radiation-induced fibrosis using liposomal Cu/Zn superoxide dismutase: clinical trial. Radiother Oncol 1994; 32: 12-20.
13. Lefaix JL, Delanian S, Leplat JJ, et al,. Successful treatment of radiation-induced fibrosis using Cu/Zn-SOD and Mn-SOD: an experimental study. Int J Radiat Oncol Biol Phys 1996; 35: 305-12.
14. Delanian S, Porcher R, Rudant J, Lefaix JL., Kinetics of response to long-term treatment combining pentoxyfullline and tocophelrol in patients with superficial radiation-induced fibrosis. J Clin Oncol 2005; 23: 8570-9.
15. Denekamp J, Bartelink H, Rubin P,. Correction for the use of the SOMA LENT tables. American and European LENT Working Committees. Radiother Oncol 1996; 39: 191.
16. Seegenschmiedt MH,. Nebenwirkungen in der Onkologie. Berlin: Springer, 1998.
17. Borger JN, Kemperman H, Smitt HS, et al,. Dose and volume effects on fibrosis after breast conservation therapy. Int J Radiat Oncol Biol Phys 1994; 30: 1073-11081.
18. Cox JD, Stetz J, Pajak TF,. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995; 31: 1341-6.
19. Pavy JJ, Denekamp J, Letschert J, et al,. Late effects toxicity scoring: the SOMA scale. Radiother Oncol 1995; 35: 11-5.
20. Bentzen SM, Overgaard M,. Early and late normal tissue injury after postmastectomy radiotherapy. Recent Results Cancer Res 1993; 130: 59-78.
21. Johansen J, Bentzen SM, Overgaard J, Overgaard M., Evidence for a positive correlation between in vitro radiosensitivity of normal human skin fibroblasts and the occurrence of subcutaneous fibrosis after radiotherapy. Int J Radiat Oncol Biol Phys 1994; 66: 407-12.
22. Bentzen SM, Overgaard M,. Realtionship between early and late normal-tissue injury after postmastectomy radiotherapy. Radiother Oncol 1991; 20: 159-65.
23. Johansen J, Bentzen SM, Overgaard J, Overgaard M., Relationship between in vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia, and skin erythema after radiotherapy. Radiother Oncol 1996; 40: 101-9.
24. Cooper JS, Fu K, Marks J, Silverman S., Late effects of radiation therapy in the head and neck region. Int J Radiat Oncol Biol Phys 1995; 31: 1141-64.
25. Marinus J, Niel CG, de Bie RA, Wiggenraad RG, Schoppink EM, Beukema LH., Measuring radiation fibrosis: The interobserver reliability of two methods of determining the degree of radiation fibrosis. Int J Radiat Oncol Biol Phys 2000; 47: 1209-17.
26. Fischer AA,. Clinical use of tissue compliance meter for documentation of soft tissue pathology. Clin J Pain 1987; 3: 23-30.
27. Fischer AA,. Muscle tone in normal persons measured by tissue compliance. J Neurol Orthop Med Surg 1987; 8: 227-34.
28. Jansen RD, Nansel DD, Slosberg M,. Normal paraspinal tissue compliance: The reliability of a new clinical and experimental instrument. J Manipulative Physiol Ther 1990; 13: 243-6.
29. Waldorf T, Devlin L, Nansel DD,. The comparative assessment of paraspinal tissue compliance in asymptomatic female and male subjects in both prone and standing positions. J Manipulative Physiol Ther 1991; 14: 457-61.
30. Sanders G, Lawson D,. Stability of paraspinal tissue compliance in normal subjects. J Manipulative Physiol Ther 1992; 15: 361-4.
31. Fischer AA,. Tissue compliance recording: method for objective documentation of soft tissue pathology. Arch Phys Med Rehabil 1981; 62: 122-5.
32. Fischer AA,. Tissue compliance meter for objective, quantitative documentation of soft tissue consistency and pathology. Arch Phys Med Rehabil 1987; 68: 122-5.
33. Wernicke AG, Parashar B, Kulidzhanov F, et al,. Prospective study validating inter- and intraobserver variability of tissue compliance meter in breast tissue of healthy volunteers: potential implications for patients with radiation-induced fibrosis of the breast. Int J Radiat Oncol Biol Phys 2010; 80 (1): 39-46.
34. Hepel JT, Tokita M, MacAusland SG, et al,. Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys 2009 Dec 1; 75 (5): 1290-6.
35. Leonard KL, Hepel JT, Hiatt JR, Price LL, DiPetrillo TA, Wazer DE,. Updates results of three-dimensional conformal accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys 2011; 81 (2): S7.
36. Martin K, Dougla A, Rakesh P, Mark R, Frank V, Breast Brachytherapy Task Group, American Brachytherapy Society. Available from: http://www. americanbrachytherapy.org.
37. Consensus statement for accelerated partial breast irradiation. The American Society of Breast Surgeons. Available from: http://www.breastsurgeons. org.
38. Statement on Partial breast irradiation. American college of Radiation Oncology. Available from: http://www.mammosite.com.
39. Benjamin DS, Douglas WA, Thomas AB, et al,. Accelerated Partial Breast Irradiation Consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys 2009; 74: 787-1001.
40. Kösters JP, Gøtzsche PC,. Regular self-examination or clinical examination for early detection of breast cancer. Cochrane Database Syst Rev 2003;(2): CD003373. doi: 10.1002/14651858.CD003373. PMID 12804462.
41. Olson JS,. Bathsheba's Breast: Women, Cancer and History. Baltimore, MD: The Johns Hopkins University Press, 2002: 198. ISBN 0-8018-6936-6. OCLC 186453370.
42. Dragun AE, Harper JL, Jenrette JM, Sinha D, Cole DJ,. Predictors of cosmetic outcome following MammoSite breast brachytherapy: a single-institution experience of 100 patients with two years of follow-up. Int J Radiat Oncol Biol Phys 2007; 68: 354-8.
43. Shah C, Ghilezan M, Arthur D, et al,. Initial clinical experience with multilumen brachytherapy catheters for accelerated partial breast irradiation. Brachytherapy 2012; 11: 369-73.